Community post

Derek Cerchione and colleagues at Editas Medicine in Cambridge have developed a new M13 phage-based directed-evolution strategy and a mutagenesis method called SMOOT to engineer Cas9 nuclease activity. They report the isolation of a Cas9 mutant that reduces off-target cleavage while preserving efficient editing at multiple on-target sites.